A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain

NCT01439919 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped due to strategic reasons

Conditions

Pain
Breakthrough Cancer Pain

Interventions

DRUG: SSR411298
DRUG: Placebo (for SSR411298)

Sponsor

Sanofi